Former CEO Ed Cox tells the story of Dthera Sciences and outlines how the digital therapeutics landscape has shifted since his company's heyday.
The virtual care startup will also look to accept additional health insurance carriers going forward.
The company hopes to maintain its momentum after a year of substantial growth.
The deal is valued at about $194 million and will drive about a third of the telemedicine company's expected revenue moving forward.
The Oxehealth Vital Signs system is installed in a patient's hospital room, where it can spot-measure pulse, heart, respiratory and breathing rates with no physical contact.
The digital therapeutic for children's ADHD symptoms received a De Novo clearance last summer.
The San Clemente, California-based company is aiming to expand its payer- and employer-focused care platform with the funds.
Published yesterday in PLoS ONE, the data suggests an alternative to the six-minute walk test often conducted in clinics to measure functional capacity.
The nearly 14-year-old company hopes to raise $75 million to support its implanted, closed-loop seizure prevention system.
Also: Boston Medical Center releases free app for clinicians treating OUD; ClearUP's OTC sinus relief device wins expanded indication.
